Kura Oncology, Inc. — Form D
Kura Oncology, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-05. The offering totals $150.0M, of which $150.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-05
- Form: D
- Accession: 0001845459-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $150.0M
- Investors: 10
- Date of first sale: 2024-01-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-504346
Issuer
- Name: Kura Oncology, Inc.
- CIK: 0001422143
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA, 92130
- Phone: (858) 500-8800
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| HELEN COLLINS | Director | SAN DIEGO, CA |
| FAHEEM HASNAIN | Director | SAN DIEGO, CA |
| THOMAS MALLEY | Director | SAN DIEGO, CA |
| DIANE PARKS | Director | SAN DIEGO, CA |
| CAROL SCHAFER | Director | SAN DIEGO, CA |
| Mary Szela | Director | Westminster, CO |
| Troy Wilson | Director | San Francisco, CA |
| Teresa Bair | Executive Officer | King City, A6 |
| STEPHEN DALE | Executive Officer | Fort Lauderdale, FL |
| KATHLEEN FORD | Executive Officer | SAN DIEGO, CA |
| BRIAN POWL | Executive Officer | SAN DIEGO, CA |
| Troy Wilson | Executive Officer | San Francisco, CA |
| Heidi Henson | Executive Officer | Seattle, WA |
| Yi Liu | Executive Officer | NEW YORK, NY |
| Pingda Ren | Executive Officer | San Diego, CA |
| ANNETTE NORTH | Executive Officer | LA JOLLA, CA |
| ANTONIO GUALBERTO | Executive Officer | LA JOLLA, CA |
Other filings by this issuer (1)
More